Simplify Asset Management’s United Therapeutics UTHR Stock Holding History

Simplify Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6M	Buy	45,411 +11,160	+33%	+$6.29M	0.34%	15
2026 Q1	$20.3M	Buy	34,251 +10,412	+44%	+$5.19M	0.31%	14
2025 Q4	$11.6M	Buy	23,839 +3,919	+20%	+$1.83M	0.19%	21
2025 Q3	$8.35M	Buy	+19,920	New	+$6.7M	0.15%	18
2023 Q1	–	Sell	-1,308	Closed	-$364K	–	132
2022 Q4	$364K	Sell	1,308 -6,606	-83%	-$1.67M	0.06%	60
2022 Q3	$1.66M	Buy	7,914 +2,475	+46%	+$553K	0.18%	33
2022 Q2	$1.28M	Buy	5,439 +1,089	+25%	+$221K	0.05%	32
2022 Q1	$780K	Buy	4,350 +2,178	+100%	+$415K	0.03%	46
2021 Q4	$469K	Buy	+2,172	New	+$426K	0.02%	44

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Simplify Asset Management's UTHR Position: Q2 2026 in Review

Simplify Asset Management increased its United Therapeutics (UTHR) stake by 33% in Q2 2026, buying an estimated $6.29M and bringing the position to 45,411 shares worth $24.6M. The position accounts for 0.34% of the portfolio, ranked #15.

Simplify Asset Management first reported a position in UTHR in Q4 2021 and has held it in 9 quarters since. 83 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Simplify Asset Management held 45,411 shares of United Therapeutics worth $24.6M as of Q2 2026.
Simplify Asset Management bought 11,160 United Therapeutics shares in Q2 2026, an estimated $6.29M.
United Therapeutics made up 0.34% of Simplify Asset Management's portfolio in Q2 2026, its #15 holding.
Simplify Asset Management first reported a position in United Therapeutics in Q4 2021 and has held it in 9 quarters since.
83 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.